Lubman Ellen 4
4 · Werewolf Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Lubman Ellen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-02+131,900→ 131,900 totalExercise: $1.56Exp: 2034-12-31→ Common Stock (131,900 underlying)
Footnotes (1)
- [F1]The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.